Summary
Definition
History and exam
Key diagnostic factors
- previous VTE, thrombophilia, malignancy, postoperative setting, trauma, and indwelling central catheter
- chronic medical conditions, paresis, increasing age, obesity, oestrogen-containing contraceptive pills and hormone replacement therapy, varicose veins, pregnancy and up to 6 weeks postnatal, first-degree relative with a history of VTE, extended travel, and admission to intensive care
Risk factors
- previous VTE (deep vein thrombosis [DVT] and/or pulmonary embolism [PE])
- thrombophilia
- malignancy
- postoperative setting
- trauma
- indwelling central catheter (upper or lower extremity)
- immobility
- myeloproliferative diseases
- congestive heart failure
- chronic obstructive pulmonary disease
- inflammatory bowel disease (IBD)
- neurological disease with extremity paresis
- increasing age
- obesity
- oestrogen-containing contraceptive pills, hormone replacement therapy (HRT), and androgen deprivation therapy
- history of varicose veins
- pregnancy/postnatal
- extended travel
- lower leg immobility
- first-degree relative with a history of VTE
- admission to intensive care
Diagnostic investigations
Treatment algorithm
Contributors
Authors
Anna L. Parks, MD
Assistant Professor
Division of Hematology
University of Utah
Salt Lake City
UT
Disclosures
ALP declares that she has no competing interests.
Acknowledgements
Dr Anna L. Parks would like to gratefully acknowledge Dr Nathalie Routhier, Dr Vicky Tagalakis, Dr Farah Zarka, Dr Vincent Bouchard-Dechêne, and Dr Adi J. Klil-Drori, previous contributors to this topic.
Disclosures
NR, FZ, VBD, and AJKD declare no competing interests. VT has received honoraria from BMS Pfizer and Bayer. She has developed educational materials for Thrombosis Canada. VT is an author of references cited in this topic.
Peer reviewers
Andrew Parfitt, MBBS, FFAEM
Clinical Director
Acute Medicine
Associate Medical Director
Consultant Emergency Medicine
Guy's and St Thomas' NHS Foundation Trust
Clinical Lead and Consultant
Accident Emergency Medicine
St Thomas' Hospital
London
UK
Disclosures
AP declares that he has no competing interests.
Sudeep Shivakumar, MD
Hematologist
Thrombosis Fellow
University of Ottawa
Ottawa Health Research Institute
Ottawa
Canada
Disclosures
SS declares that he has no competing interests.
References
Key articles
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(suppl 2):e227S-77S.Full text Abstract
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325.Full text Abstract
Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141 (2 Suppl):e195S-226S.Full text Abstract
National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. Aug 2019 [internet publication].Full text
Nicolaides AN, Fareed J, Spyropoulos AC, et al. Prevention and management of venous thromboembolism. International consensus statement (guidelines according to scientific evidence). Int Angiol. 2024 Feb;43(1):1-222.Full text
Reference articles
A full list of sources referenced in this topic is available here.
Use of this content is subject to our disclaimer